News Detail
New Delhi, 14 Oct 2024: Drug firm Glenmark is recalling two products in the US due to manufacturing issues, according to the US Food and Drug Administration. New Jersey-based Glenmark Pharmaceuticals Inc, USA, a unit of Mumbai-based Glenmark Pharmaceuticals, is recalling 45,504 b......
View Details
Source : PTI
Glenmark recall
USFDA
Ryaltris nasal spray
Ciclopirox Gel
manufacturing issues
defective delivery system
Glenmark Pharmaceuticals Inc
USA
drug recall
glenmark pharmaceuticals
Related News
- 11 countries recognised IP as their standard: DCGI Rajeev Raghuvanshi (14-10-2024)
- DTAB asks DCC to look into inclusion of all antibiotics in the definition of new drugs to curb AMR (14-10-2024)
- DGFT extends RoDTEP scheme for pharma exporters until Dec 31 (14-10-2024)
- India’s copycat drugmakers gear up to offer cheaper weight-loss drugs (14-10-2024)
- Gwalior: Collector instructed to closely inspect the medicine manufacturing factories (14-10-2024)
- MP: 3 Listed Criminals arrested With Prohibited Drugs in Umaria (14-10-2024)
- Five fake drug inspectors arrested, used to extort money from medical store operators (13-10-2024)
- A comprehensive regulatory model to ensure safety and quality of medical devices (13-10-2024)
- Bengaluru Police push for tougher Drugs and Cosmetics Act to combat recreational drug sales (13-10-2024)
- 413 Codril-T Cough Syrup Bottles Seized, 3 Held (13-10-2024)